Updated:
PoC Capital
PoC Capital was established in 2015 by Daron Evans. The office manages capital originating from his executive and advisory positions in life-science companies.
PoC Capital
PoC Capital was established in 2015 by Daron Evans. The office manages capital originating from his executive and advisory positions in life-science companies. The firm invests directly in small public life-science companies. It provides funding specifically for proof-of-concept clinical trials that validate safety and efficacy. Investment types include direct co-investments and SPVs alongside hedge-fund exposure. Activity centers on North America. Daron Evans serves on the Board of Trustees of the Buck Institute for Research on Aging. The Evans Family Foundation operates as a separate philanthropic vehicle. No additional offices or team-size figures are disclosed.
General information
Firm type
Single Family Office
Year founded
2015
Location
Region
North America
Country
United States
City
Woodside
Corporate office
Woodside, CA, United States
Principals
Daron Evans
Founder and CEO
Sector focus
Frequently asked questions
Who runs investment decisions at PoC Capital?
Daron Evans serves as Founder and CEO and directs investment decisions. He previously held CEO and CFO roles at NephroGenex and Nile Therapeutics.
How does PoC Capital source proprietary deal flow?
The firm evaluates inbound opportunities that fit its parameters for proof-of-concept clinical trials in life sciences. Contact is directed through info@poccap.com.
Is PoC Capital structured as a single family office or does it operate more like a venture firm?
It is organized as a single-family office. Deployment occurs through direct co-investments and SPVs rather than a traditional venture-fund structure.
Does PoC Capital participate in fund commitments or only direct deals?
The firm executes direct co-investments and SPVs. It also maintains exposure to hedge funds.
What investment stages does PoC Capital typically target?
The firm focuses on early-stage opportunities where proof-of-concept clinical trials can unlock value in development-stage assets.
Where does the underlying wealth come from?
Capital originates from Daron Evans' executive, investment and advisory roles in public and private life-science enterprises.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: